Somatostatin and the Gastrointestinal Tract

REFERENCES

• Krulich L, Dhariwal APS, McCann SMS. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 1968;83:783–90.
   Google Scholar
• Schusdziarra V. Physiological significance of gastrointestinal somatostatin. Hormone Res 1988;29:75–8.
   PubMedGoogle Scholar
• Buchler M, Friess M, Klempa I. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Amer J Surg 1992;163:125–31.
   Google Scholar
• Persson B, Slezak P, Efendic S. Can somatostatin prevent injection pancreatitis after ERCP? Hepato-Gastroenterol 1992; 39:259–61.
   Google Scholar
• Burroughes AK, McCormick . Somatostatin and octreotide in gastroenterology. Aliment Pharmacol Therap 1991;5:331–41.
   PubMed Web of Science ®Google Scholar
• Magnusson I, Ihre T, Johansson C. Randomized double-blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 1985;26:221–6.
   Google Scholar
• Torres AJ, Landa I, Hernandez F. Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicenter controlled trial. Brit J Surg 1986;73:786–9.
   Google Scholar
• Tulassay Z, Gupta R, Papp J, Bodnar A. Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: A prospective, randomized, controlled trial. Amer J Gastroenterol 1989;84:6–9.
   PubMed Web of Science ®Google Scholar
• Christiansen J, Ottenjann R, von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201–995 in peptic ulcer bleeding. Gastroenterology 1989;97:568–74.
   Google Scholar
• Sung JJY, Chung SCS, Lai ChW, Chan FKL, Leung JWC, Yung MY, Kassianides Ch, Li AKC. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993;342:637–41.
   PubMed Web of Science ®Google Scholar
• Besson I, Ingrand P, Person B, Boutroux D. Sclerotherapy with or without octreotide for acute variceal bleeding. New Engl J Medicine 1995;333:555–60.
   PubMed Web of Science ®Google Scholar
• Goetzche PC, Gjorup I, Bonnen H, Brahe NE, Becker U, Burcharth F. Somatostatin versus placebo in bleeding oesophageal varices: randomised trial and meta-analysis. Brit med J 1995;310:1495–8.
   PubMed Web of Science ®Google Scholar
• Ceriani R, Curioni R, Morini L, Repaci G, Brunati S. Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal bleeding. Gastroenterology 1997;112:A 1238.
   Google Scholar
• Ingrand P, Rodriguez B, Silcain C, Beauchant M. Predictive factors of early varieal bleeding control after amergency sclerotherapy: role of octreotide. Gastroenterology 1997;112:A 1289.
   Web of Science ®Google Scholar
• Valenzuela JE, Schubert T, Fogel MR, STrong RM, Levine J, Mills PR, Fabry TL, Tayler LW, Conn HO, Posillico JT. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989;10:958–61.
   PubMed Web of Science ®Google Scholar
• Jenkins SA, Berein A. Review article: the relative effectiveness of somatostatin and octreotide therapy in pancreatic disease. Aliment Pharmacol Ther 1995;9:349–61.
   PubMed Web of Science ®Google Scholar
• Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J. Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut 1989;30:223–7.
   PubMed Web of Science ®Google Scholar
• D’Amico D, Favia C, Biasiato R. The use of somatostatin in acute pancreatitis: results of a multicentre trial. Hepato- Gastroenterol 1990;37:92–8.
   Google Scholar
• O’Hair DP, Hoffman RG, Schroeder H, Wilson SD. Octreotide in the treatment of acute pancreatitis: A prospective randomised trial. Gastroenterology 1993;104:A326.
   Google Scholar
• Pederzoli P, Bassi C, Falconi I, Camboni MH. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994;81:265–9.
   PubMed Web of Science ®Google Scholar
• Tulassay Z, Kisfalvi K, Papp M. The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats. Z Gastoenterol 1995;33:99–102.
   Google Scholar
• Uhl W, Malfertheiner F, Adler G, Bruch HP, Lankisch PF, Lorenz D, Gaus W, Berger HG, Biichler MW. A randomized controlled multicentric trial on the role of octreotide in human acute pancreatis. Gastroenterology 1997;112:A 488.
   Google Scholar
• Arcidianono R, Gamitta P, Rossi A. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 1994;26: 715–8.
   Google Scholar
• Binmoeller KF, Harris AG, Dumas R, Grimaldi C, Delmont JP. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 1992;33:1129–33.
   Google Scholar
• Gostout CJ. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1993;88:2138–9.
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Barkun A, Denis MH, Pollak M. Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. Cancer 1995;75:23–8.
   PubMed Web of Science ®Google Scholar
• Tulassay Z, Papp J. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic panceatography. Gastrointestinal Endoscopy 1991;37:48–50.
   PubMed Web of Science ®Google Scholar
• Guelrud M, Mendoza S, Viera I, Guelrud D. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic ballon dilatation in patients with idiopathic recurrent pancreatitis. Gastrointestinal Endoscopy 1991;37:44–7.
   PubMed Web of Science ®Google Scholar
• Sternlieb JM, Aronchick CA, Retic JN. A multicentre randomised controlled trial to evaluate the effects of prophylactic octreotide on ERCP-induced acute pancreatitis. Am J Gastroenterol 1992;87:1561–6.
   Google Scholar
• Döbrönte Z, Juhász L, Tulassay Zs. Octreotid az endoszkópos retrográd cholangiopancreatographiát követô hyperamylasaemia prevenciojaban. Multicentrikus kontrollalt tanulmâny. Orv Hetil 1996;137:2309–12.
   PubMedGoogle Scholar
• Tulassay Z, Flautner L, Sándor Z, Fehérvári I. Perioperative use of somatostatin in pancreatic surgery. Acta Biomedica 1993;64: 205–11.
   PubMedGoogle Scholar
• Rosenberg L, McNeil P, Turcotte L. Cost-effectiveness analysis of octreotide in prevention of complications following pancretic resection. Gastroenterology, 1997;112:A 1470.
   Google Scholar
• Lansden FT, Adams DB, Anderson MC. Treatment of external pancreatic fistulas with somatostatin. Am Surg 1989;55:695–8.
   Google Scholar
• Torres AJ, Landa JI, Moreno-Azecita M. Somatostatin in the management of gastrointestinal fistulas. A multicentre trial. Arch Surg 1992;127:97–9.
   Google Scholar
• Tulassay Z, Flautner L, Vadász A, Fehérvári I. Short report: octreotide in the treatment of external pancreatic fistulas. Aliment Pharmacol Ther 1993;7:323–5.
   PubMed Web of Science ®Google Scholar
• Tulassay Z, Flautner L, Fehérvári I. Octreotide. Lancet 1992; 339:1428.
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Barkun A, Denis MH, Pollak M. Low-dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. Cancer 1995;75:23–8.
   PubMed Web of Science ®Google Scholar
• Arnold R, Benning R, Neuhaus C, Rolwage M, Trautmann ME. Gastroenteropancreatic endocrine tumours: Effect of Sandosta- tin on tumour growth. Digestion 1993;54:72–5.
   Google Scholar
• Bagarani M, Albertini V, Anza M, Bariattani A, Bracci F, Gucchiari G, Gizzonio D, Grassini G, Mari T, Procacciante F. Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci 1987;17:21–6.
   PubMedGoogle Scholar
• Saari A, Kivilaakso E, Inberg M, Paakkonen M, Lahtinen J, Hocherstedt K, Schroder T. Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol 1990;85:804–7.
   Google Scholar
• Walker S, Kreichgauer HD, Bode JC. Terlipressin vs somatostatin in bleeding esophageal carices: a controlled, doubleblind study. Hepatology 1992;15(6):123–30.
   Google Scholar
• Huang CC, Sheen IS, Chu CM, Chuah SK, Chien RN, Peng SM, Kou YC, Lin SM, Lin Dy, Chen PC. A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices. Chang Gung Med J 1992;15:78–83.
   Google Scholar
• Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, Wang SS, Lee SD, Tsai YT, Lo KJ. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992;16:320–5.
   PubMed Web of Science ®Google Scholar
• Silvai C, Carpentier S, Sautereau D. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993;18:61–5.
   Google Scholar
• Testoni PA, Lella R, Gagnolo F. Controlled trial of different dosages of octreotide in the prevention of hyperamylasaemia induced by endoscopic papillosphincterotomy. Ital J Gastroenterol 1994;26:431–6.
   Google Scholar